Adcentrx Therapeutics - About the company
Adcentrx Therapeutics is a series A company based in San Diego (United States), founded in 2021 by Hui Li. It operates as a Developer of next-generation targeted therapies for cancer. Adcentrx Therapeutics has raised $101M in funding from Eight Roads Ventures and CBC Group. The company has 3315 active competitors, including 1123 funded and 782 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, BeiGene and Sana Biotechnology.
Company Details
Developer of next-generation targeted therapies for cancer. The antibody-drug conjugate is developed that targets specific tumors for the treatment of a variety of cancers.
- Website
- www.adcentrx.com/
- Email ID
- *****@adcentrx.com
Key Metrics
Founded Year
2021
Location
San Diego, United States
Stage
Series A
Total Funding
$101M in 3 rounds
Latest Funding Round
Investors
Ranked
451st among 3315 active competitors
Investment & Acquisitions
Similar Companies
Sign up to download Adcentrx Therapeutics' company profile
Adcentrx Therapeutics's funding and investors
Adcentrx Therapeutics has raised a total funding of $101M over 3 rounds. Its first funding round was on Apr 28, 2021. Its latest funding round was a Series A round on Dec 06, 2023 for $*****. 3 investors participated in its latest round. Adcentrx Therapeutics has 9 institutional investors.
Here is the list of recent funding rounds of Adcentrx Therapeutics:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Dec 06, 2023 | 7885407 | Series A | 2555579 | 1132060 | 3442371 | 1283846 |
Apr 25, 2023 | 6976578 | Series A | 6446747 | 6982435 | 1921083 | |
Apr 28, 2021 | 5778912 | Series A | 6963076 | 2053900 | 5221965 |
Access funding benchmarks and valuations. Sign up today!View details of Adcentrx Therapeutics's funding rounds and investors
Adcentrx Therapeutics' founders and board of directors
Founder? Claim ProfileHere are the details of Adcentrx Therapeutics' key team members:
- Hui Li: Founder & CEO & President of Adcentrx Therapeutics.
View details of Adcentrx Therapeutics's Founder profiles and Board Members
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Adcentrx Therapeutics's Competitors and alternates
Top competitors of Adcentrx Therapeutics include Jazz Pharmaceuticals, BeiGene and Sana Biotechnology. Here is the list of Top 10 competitors of Adcentrx Therapeutics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Jazz Pharmaceuticals 2003, Dublin (Ireland), Public | Developer of novel biopharmaceutical medicines for unmet medical needs | $265M | 82/100 | |
2nd |  BeiGene 2010, Cambridge (United States), Public | Developer of targeted and immune-oncology drugs against cancer | $172M | 80/100 | |
3rd |  Sana Biotechnology 2018, Seattle (United States), Public | Developer of engineered cell therapies for treating various human diseases | $821M | 73/100 | |
4th | Ideaya Biosciences 2015, San Francisco (United States), Public | Developer of oncology-focused precision medicine using molecular diagnostics | $157M | 73/100 | |
5th | Senti Bio 2016, San Francisco (United States), Public | Developer of cell and gene therapies for patients living with incurable diseases | $158M | 72/100 | |
6th | Sutro Biopharma 2003, United States, Public | Developer of antibody-based therapeutics for cancer therapy | $175M | 72/100 | |
7th | Syndax 2005, Waltham (United States), Public | Developer of targeted therapies for the treatment of cancer | $198M | 72/100 | |
8th |  Moderna 2010, Cambridge (United States), Public | Developer of mRNA-based therapeutics for a wide range of diseases | $2.78B | 71/100 | |
9th | Developer of T-cell therapies for the treatment of cancer | $49.8M | 71/100 | ||
10th | C4 Therapeutics 2016, Cambridge (United States), Public | Developer of small molecule drugs for treating cancer | $223M | 71/100 | |
451st | Adcentrx Therapeutics 2021, San Diego (United States), Series A | Developer of next-generation targeted therapies for cancer | $101M | 53/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Adcentrx Therapeutics's competitors? Click here to see the top ones
Adcentrx Therapeutics's Investments and acquisitions
Adcentrx Therapeutics has a total of 1 investment in Momotaro-Gene. Adcentrx Therapeutics has not made any acquisitions as of now.Reports related to Adcentrx Therapeutics
Here is the latest report on Adcentrx Therapeutics's sector:
News related to Adcentrx Therapeutics
Filter this listMedia has covered Adcentrx Therapeutics for 1 event in last 1 year.
•
•
•
Adcentrx launches Phase 1 for its next-generation ADC targeting advanced solid tumorsBioPharma-Reporter•Jan 07, 2025•Adcentrx Therapeutics
•
•
•
Adcentrx Therapeutics Announces Formation of Scientific Advisory BoardPR Newswire•Sep 10, 2024•Adcentrx Therapeutics
•
•
Adcentrx Raised $13M in Series A+ Financing, Totaling $51MSilicon Valley Journals•Dec 06, 2023•Adcentrx Therapeutics, Quan Capital, Partners Investment, Eight Roads Ventures
•
Our investment in Adcentrx TherapeuticsEight Roads Ventures•Oct 23, 2023•Eight Roads Ventures, Adcentrx Therapeutics, F-Prime Capital, Delta Capita and 3 others
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Adcentrx Therapeutics
Explore our recently published companies
- Iconic Guam Homes - United States based, Unfunded company
- Dimaaya Yad Consulting - United Arab Emirates based, Unfunded company
- Peikh - Mumbai based, Unfunded company
- Category Pirates - Unfunded company
- VRR Diagnostics - India based, 1987 founded, Unfunded company
- CoraHack - New York based, 2024 founded, Unfunded company
